Publication
The EU is currently working on a legal framework for new genomic techniques (NGTs). A step that is long overdue. However, over the course of the legislative process, there have been recurring calls to deny basic patent protection to plants and plant material bred using NGTs, thereby weakening the established Biopatent Directive. This is not appropriate and threatens legal certainty far beyond the plant sector.
- Publication
- 4 Pages / DIN A4
- Target group
- General public
Biotechnology: Safeguarding patentability is essential
From the contents
- Biotechnology: Safeguarding patentability is essential
- Plant variety protection + patent law = innovative strength in plant breeding
- Innovation ecosystem of immeasurable value
- Farmers are not affected by patent law
Contact
For questions or suggestions, please feel free to contact us.
RA Marcel Kouskoutis
Gewerbliche Schutzrechte, Kartellrecht, Rechtsfragen Digitalisierung, Zivil- und Vertragsrecht
- E-mail: kouskoutis@vci.de